lamotrigine
Generic: lamotrigine
Labeler: torrent pharmaceuticals limitedDrug Facts
Product Profile
Brand Name
lamotrigine
Generic Name
lamotrigine
Labeler
torrent pharmaceuticals limited
Dosage Form
TABLET, ORALLY DISINTEGRATING
Routes
Active Ingredients
lamotrigine 200 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
13668-696
Product ID
13668-696_1a7c93f4-7ede-4574-b2f5-5d01dc87cdf8
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA217100
Listing Expiration
2027-12-31
Marketing Start
2026-01-08
Pharmacologic Class
Established (EPC)
Mechanism of Action
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
13668696
Hyphenated Format
13668-696
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lamotrigine (source: ndc)
Generic Name
lamotrigine (source: ndc)
Application Number
ANDA217100 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 mg/1
Packaging
- 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (13668-696-01)
- 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (13668-696-30)
- 30 BLISTER PACK in 1 CARTON (13668-696-72) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (13668-696-71)
Packages (3)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "1a7c93f4-7ede-4574-b2f5-5d01dc87cdf8", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "upc": ["0313668696301", "0313668693300", "0313668695304", "0313668694307"], "unii": ["U3H27498KS"], "rxcui": ["103968", "198430", "252478", "252479"], "spl_set_id": ["22225cc4-028e-43ad-8e1f-dcebdc244ecb"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "manufacturer_name": ["Torrent Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (13668-696-01)", "package_ndc": "13668-696-01", "marketing_start_date": "20260108"}, {"sample": false, "description": "30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (13668-696-30)", "package_ndc": "13668-696-30", "marketing_start_date": "20260108"}, {"sample": false, "description": "30 BLISTER PACK in 1 CARTON (13668-696-72) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (13668-696-71)", "package_ndc": "13668-696-72", "marketing_start_date": "20260108"}], "brand_name": "LAMOTRIGINE", "product_id": "13668-696_1a7c93f4-7ede-4574-b2f5-5d01dc87cdf8", "dosage_form": "TABLET, ORALLY DISINTEGRATING", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Dihydrofolate Reductase Inhibitors [MoA]", "Mood Stabilizer [EPC]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "13668-696", "generic_name": "LAMOTRIGINE", "labeler_name": "Torrent Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LAMOTRIGINE", "active_ingredients": [{"name": "LAMOTRIGINE", "strength": "200 mg/1"}], "application_number": "ANDA217100", "marketing_category": "ANDA", "marketing_start_date": "20260108", "listing_expiration_date": "20271231"}